{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-26-000050","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2026-06-24T20:05:56+00:00","discovered_at":"2026-06-24T20:07:01.441173+00:00","generated_at":"2026-06-24T20:07:47.320658+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Elicio hosts KOL event on ELI-002 7P for metastatic mKRAS PDAC; no new data disclosed","bullets":["Virtual KOL event on June 24, 2026 featured Dr. Zev Wainberg (UCLA) and Dr. Peter Hosein (U. Miami).","Event discussed path forward for ELI-002 7P in metastatic mutant KRAS-driven pancreatic ductal adenocarcinoma.","No specific clinical data, enrollment updates, or financial guidance were included in the filed material."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-26-000050","json":"https://secwatch.observer/filing/0001601485-26-000050.json","markdown":"https://secwatch.observer/filing/0001601485-26-000050.md","text":"https://secwatch.observer/filing/0001601485-26-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000050/0001601485-26-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000050/angn-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:07:47.320658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}